Outcomes & Impacts

web3

From April 1, 2005, to March 31, 2015, AllerGen supported 174 research projects, investing over $40 million in Network research and strategic initiatives. Outcomes of these projects have resulted in 39 innovation products (patents, start-up companies, copyrights, industry licenses, etc.), over 3600 publications, 56 research workshops, six Caf├ęs Scientifiques, training and capacity building for over 1300 Highly Qualified Personnel (HQP), and a wealth of knowledge, technologies, tools and educational materials that will improve the quality of life for Canadians living with asthma, allergies and related immune disease.


AllerGen’s Global Reach

AllerGen is committed to sharing its research findings, not only within Canada, but across the globe. AllerGen-funded research has been disseminated worldwide through journal articles, media releases, and conference and poster presentations delivered in more than 35 countries, including developing nations such as Argentina, Brazil, El Salvador, India, Thailand and Uganda. (Click on the image below to see an enlarged version.)

global